Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outset Medical (OM) EBIT Margin (2019 - 2025)

Outset Medical (OM) has disclosed EBIT Margin for 7 consecutive years, with 61.05% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 1313.0% to 61.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 55.83% through Dec 2025, up 4389.0% year-over-year, with the annual reading at 55.83% for FY2025, 4389.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 61.05% at Outset Medical, down from 53.73% in the prior quarter.
  • The five-year high for EBIT Margin was 53.68% in Q2 2025, with the low at 174.49% in Q2 2022.
  • Average EBIT Margin over 5 years is 111.03%, with a median of 120.02% recorded in 2022.
  • The sharpest move saw EBIT Margin skyrocketed 18160bps in 2021, then tumbled -5589bps in 2022.
  • Over 5 years, EBIT Margin stood at 144.92% in 2021, then grew by 14bps to 124.42% in 2022, then rose by 2bps to 122.44% in 2023, then surged by 39bps to 74.18% in 2024, then increased by 18bps to 61.05% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 61.05%, 53.73%, and 53.68% for Q4 2025, Q3 2025, and Q2 2025 respectively.